Hong Kong Stock Market Buzz | Aimeoncang Technology-B (01541.HK) Surges Nearly 4% as Self-developed Amurifo Subcutaneous Formulation IMM0306S Clinical Study Application Accepted

According to the Zhitong Financial APP, Yiming Angke-B (01541.HK) has risen by nearly 4%, as of the time of publication, it has risen by 2.98%, closing at 6.23 Hong Kong dollars, with a turnover of 3.1192 million Hong Kong dollars.